Starling Oncology, Inc. Common Stock (STLN) is a publicly traded the market company. As of August 6, 2026, STLN trades at $5.83 with a market cap of $502.91M and a P/E ratio of 0.00. STLN moved -0.60% today. Year to date, STLN is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $4.85 to $5.29. Rallies surfaces STLN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks STLN insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $5.83 |
| Market Cap | $502.91M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.29 |
| 52-Week Low | $4.85 |
| Volume | 1.45M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
STLN analyst coverage data. Average price target: $0.00.